Trials / Unknown
UnknownNCT05097560
The Effect of HFNC on Exercise Capacity Compared to VM in COPD Patients Recovering From Acute Evacerbation
The Effect of High Flow Nasal Cannula on Exercise Capacity Compared to Venturi Mask in COPD Patients Recovering From Acute Evacerbation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Early PR is thought to be effective in COPD patients recovering from acute exacerbation, while the effect of HFNC during exercise training in these patients remains unclear. The study may provide evidence of early PR in COPD patients recovering from acute exacerbation.
Detailed description
We hypothesize that HFNC may increases exercise time in COPD patients recovering from acute exacerbation compare to VM. A randomized, cross-over clinical trial in which either HFNC or VM may be used as an adjunct in 10-MST in random order, respectively, will be performed to compare the endurance time. The physiological effect of HFNC and VM during exercise will also be measured to explore the mechanism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | high flow nasal cannula | HFNC provides humidified, heated, oxygen-enriched air at constant concentration with a flow up to 60L/min through a nasal cannula. It washouts the anatomical dead space and decreases the work of breathing. |
| DEVICE | Venturi mask | VM is commonly used by COPD patients during exercise training. |
Timeline
- Start date
- 2021-08-11
- Primary completion
- 2022-05-31
- Completion
- 2022-08-31
- First posted
- 2021-10-28
- Last updated
- 2021-10-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05097560. Inclusion in this directory is not an endorsement.